Draft:Hinge Health
Wikipedia articles must be written neutrally in a formal, impersonal, and dispassionate way. They should not read like a blog post, advertisement, or fan page.
Submission declined on 6 July 2026 by Theroadislong (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
Comment: In accordance with the Wikimedia Foundation's Terms of Use, I disclose that I have been paid by my employer for my contributions to this article. MagicContentHere (talk) 23:03, 29 June 2026 (UTC)
Hinge Health
Hinge Health, Inc. is an American digital health company headquartered in San Francisco, California.[1] It provides musculoskeletal, women's pelvic health, and migraine care through a platform combining digital exercise therapy, wearable devices, and clinical support.[2] The company sells primarily to self-insured employers and health plans, which offer the service as a covered benefit to employees and members.[3] Its shares trade on the New York Stock Exchange under the ticker symbol HNGE.[4]
History
Hinge Health was founded in 2014 by Daniel Perez and Gabriel Mecklenburg, who met while pursuing doctoral degrees in the United Kingdom; Perez at the University of Oxford and Mecklenburg at Imperial College London.[5] Both founders had personal experience with musculoskeletal injuries: Perez sustained bone fractures in a cycling accident, while Mecklenburg tore his ACL during a judo match.[6] Those experiences, and frustration with existing care pathways, shaped the company's direction.[7] The company initially operated in London, United Kingdom, prior to relocating to San Francisco, California, in 2017.[8]
Leadership
The company is led by co-founder and chief executive officer Daniel Perez, who attended a doctoral program in biochemistry at the University of Oxford. Co-founder Gabriel Mecklenburg serves as the executive chairman.[9]
Products and services
Hinge Health's core platform focuses on musculoskeletal conditions including joint and muscle pain and post-surgical rehabilitation.[10] The service combines digital exercise therapy with AI-powered motion-tracking technology, called TrueMotion, and support from a remote clinical team.[11]
The company markets an FDA-cleared wearable device called Enso, which uses non-invasive electrical nerve stimulation for pain relief.[12] An updated version, Enso 3, was released in 2024.[13] The device subsequently received FDA clearance for migraine treatment in 2026.[14]
In 2022, Hinge Health expanded its offerings to include women's pelvic floor care within its digital platform.[15] The program addresses issues including prolapse, bladder and bowel dysfunction, abdominal separation, and chronic pelvic pain.[16]
Hinge Health launched HingeSelect in 2025, a curated referral network connecting members to in-person physical therapy providers, imaging centers, and orthopedic surgeons for cases where in-person or surgical care is needed.[17]
In 2026, the company launched a migraine care program combining the Enso device, AI-assisted trigger tracking, and exercise therapy.[18]
Business model
The company sells to self-insured employers, health plans, pharmacy benefit managers and third-party administrators, which offer the platform to employees and members at no direct cost. Clients pay annual fees based on active member engagement.[19] As of the end of 2025, Hinge Health reported approximately 2,830 enterprise clients and 25 million contracted lives.[20]
Financials
| Round | Details |
|---|---|
| Series A | $8 million, led by Atomico[21], to develop its digital musculoskeletal therapy platform |
| Series B | $26 million, led by Insight Venture Partners[22], with participation from Atomico |
| Series C | $90 million, led by Bessemer Venture Partners[23], with Lead Edge Capital and existing investors. Valuation at the time was approximately $420 million |
| Series D | $300 million, led by Coatue Management and Tiger Global[24], valuing the company at $3 billion |
| Series E | $400 million, led by Coatue Management and Tiger Global[25], valuing Hinge Health at $6.2 billion. Alkeon Capital and Whale Rock contributed an additional $200 million in secondary investment. At the time among the highest private valuations in digital health.[26] |
Hinge Health filed for an initial public offering in March 2025.[27] Its shares began trading on the New York Stock Exchange on May 22, 2025, under the ticker symbol HNGE, after the company and certain existing shareholders raised $437.3 million in the offering.[28] The IPO priced at $32.00 per share, giving the company a fully diluted valuation of approximately $2.9 billion.[29] Shares opened at $39.25, up roughly 23 percent from the offering price, and closed at $37.56, bringing the market capitalization above $3 billion.[30] The listing was reported as a signal of investor appetite for digital health companies following several years of limited public-market activity in the sector.[31] [32] [33] [34]
For fiscal year 2025, Hinge Health reported revenue of $587.9 million, non-GAAP operating income of $119.5 million, and free cash flow of $179.6 ,million.[35] The company projects its full year 2026 revenue guidance to be in the range of $818 million to $824 million, a 40 percent YoY growth at the midpoint.[36]
| Year | Revenue | Non-GAAP operating income | Free cash flow |
|---|---|---|---|
| 2024 | $390.4 million | $26.1 million | $45.2 million |
| 2025 | $587.9 million | $119.5 million | $179.6 million |
See also
- Digital health Digital health
- Musculoskeletal disorder [[1]]
- Musculoskeletal injury Musculoskeletal injury
- Migraine [[2]]
- Telehealth Telehealth
References
- ^ https://www.businessinsider.com/investors-executives-got-rich-hinge-health-ipo-2025-5#atomico-an-investor-309-million-3
- ^ https://www.mobihealthnews.com/news/hinge-health-goes-public-raises-4373m-ipo
- ^ https://www.mobihealthnews.com/news/hinge-health-goes-public-raises-4373m-ipo
- ^ https://www.mobihealthnews.com/news/hinge-health-goes-public-raises-4373m-ipo
- ^ https://www.cnbc.com/2025/05/05/from-cockroach-award-to-big-board-hinge-health-unlikely-path-to-ipo.html
- ^ https://www.cnbc.com/2025/05/05/from-cockroach-award-to-big-board-hinge-health-unlikely-path-to-ipo.html
- ^ https://www.cnbc.com/2025/05/05/from-cockroach-award-to-big-board-hinge-health-unlikely-path-to-ipo.html
- ^ https://www.businessinsider.com/investors-executives-got-rich-hinge-health-ipo-2025-5#atomico-an-investor-309-million-3
- ^ https://www.cnbc.com/2025/05/05/from-cockroach-award-to-big-board-hinge-health-unlikely-path-to-ipo.html
- ^ https://www.mobihealthnews.com/news/hinge-health-goes-public-raises-4373m-ipo
- ^ https://www.mobihealthnews.com/news/hinge-health-goes-public-raises-4373m-ipo
- ^ https://www.mobihealthnews.com/news/hinge-health-goes-public-raises-4373m-ipo
- ^ https://www.massdevice.com/hinge-health-new-wireless-pain-relief-device/
- ^ https://www.benefitnews.com/news/why-migraine-support-needs-to-be-part-of-your-chronic-care-strategy
- ^ https://www.mobihealthnews.com/news/msk-company-hinge-health-launches-program-female-pelvic-floor-disorders
- ^ https://www.fastcompany.com/90745778/women-have-a-new-digital-option-for-improving-pelvic-health
- ^ https://www.fiercehealthcare.com/digital-health/hinge-health-stock-surges-it-reports-strong-revenue-growth-free-cash-flow-following
- ^ https://www.benefitnews.com/news/why-migraine-support-needs-to-be-part-of-your-chronic-care-strategy
- ^ https://www.fiercehealthcare.com/digital-health/hinge-health-projects-2026-revenue-hit-732m-buoyed-strong-growth-investments-ai
- ^ https://www.fiercehealthcare.com/digital-health/hinge-health-projects-2026-revenue-hit-732m-buoyed-strong-growth-investments-ai
- ^ https://www.cnbc.com/2025/05/05/from-cockroach-award-to-big-board-hinge-health-unlikely-path-to-ipo.html
- ^ https://techcrunch.com/2018/08/09/hinge-health-b/
- ^ https://www.mobihealthnews.com/news/hinge-healths-90m-series-c-will-double-its-staff-fuel-product-development
- ^ https://www.mobihealthnews.com/news/hinge-health-now-valued-3b-following-300m-series-d
- ^ https://www.mobihealthnews.com/news/msk-startup-hinge-health-lands-600m-new-investments
- ^ https://www.fiercehealthcare.com/health-tech/hinge-health-shares-jump-17-stock-market-setting-stage-digital-health-ipo-revival
- ^ https://www.businessinsider.com/investors-executives-got-rich-hinge-health-ipo-2025-5
- ^ https://www.mobihealthnews.com/news/hinge-health-goes-public-raises-4373m-ipo
- ^ https://www.fiercehealthcare.com/health-tech/hinge-health-shares-jump-17-stock-market-setting-stage-digital-health-ipo-revival
- ^ https://www.cnbc.com/2025/05/22/hinge-health-shares.html
- ^ https://www.wsj.com/articles/hinge-health-goes-public-delivering-much-needed-win-for-digital-health-startups-da641ebc?mod=author_content_page_1_pos_1
- ^ https://www.healthcaredive.com/news/digital-health-ipo-window-open-uncertainty-challenges-mergers-acquisitions/803446/
- ^ https://www.fiercehealthcare.com/digital-health/hlth25-hinge-health-and-omada-broke-digital-health-ipo-dry-spell-ceos-share-their
- ^ https://endpoints.news/hinge-health-pops-23-as-the-digital-health-ipo-market-reawakens/
- ^ https://www.wsj.com/articles/hinge-health-goes-public-delivering-much-needed-win-for-digital-health-startups-da641ebc?mod=author_content_page_1_pos_1
- ^ https://www.quiverquant.com/news/Hinge+Health+gains+as+investors+continue+to+respond+to+raised+2026+outlook
Content Disclaimer
Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.
- The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
- There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
- It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
- Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
- Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.
Wikipedia articles must be written neutrally in a formal, impersonal, and dispassionate way. They should not read like a blog post, advertisement, or fan page. Rewrite the draft to remove:
Instead, only summarize in your own words a range of independent, reliable, published sources that discuss the subject.
If you have a conflict of interest (e.g. you are the subject, an employee, or a relative) or are being paid to edit, you must disclose this to comply with Wikipedia's Terms of Use.